Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey

BACKGROUND: Magnesium sulphate (MgSO(4)) is the only treatment approved for fetal neuroprotection. No information on its use is available in the absence of a national registry of neonatal practices. The objective of our study was to evaluate the use of MgSO(4) for fetal neuroprotection in French ter...

Descripción completa

Detalles Bibliográficos
Autores principales: Chollat, Clément, Le Doussal, Lise, de la Villéon, Gaëlle, Provost, Delphine, Marret, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596870/
https://www.ncbi.nlm.nih.gov/pubmed/28903747
http://dx.doi.org/10.1186/s12884-017-1489-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596870/
https://www.ncbi.nlm.nih.gov/pubmed/28903747
http://dx.doi.org/10.1186/s12884-017-1489-z

Ejemplares similares